What Is The Biological Mechanism Behind Androgenic Effects On Hair Follicles, And How Does It Influence Laser Hair Removal And Hair Growth Equipment Protocols? Key Insights For Clinical Success.

Androgenic effects on hair follicles are location-dependent: the same hormones can stimulate terminal hair growth on the face and body while causing follicle miniaturization on genetically susceptible scalp regions. This occurs because follicles differ in androgen-receptor activity, local conversion of testosterone to dihydrotestosterone (DHT), and genetic responsiveness. These differences determine both how hair responds biologically and how laser hair removal or hair-growth equipment should be planned.

The key principle is that androgen sensitivity belongs to the individual follicle, not the entire body. Hair-removal protocols must account for ongoing hormonal stimulation and hair-cycle timing, while hair-growth protocols must address androgen-driven miniaturization rather than treating all scalp follicles as biologically identical.

Why Androgens Produce Opposite Hair Effects

Testosterone and DHT Activate Local Follicle Signaling

Testosterone can be converted into DHT by the enzyme 5α-reductase within the pilosebaceous unit and surrounding scalp or follicular cells. DHT then binds to androgen receptors in susceptible follicles, changing gene activity and the behavior of the dermal papilla and matrix.

The result depends on the follicle's anatomical location and inherited sensitivity. Circulating hormone levels matter, but the follicle's local receptor and enzyme activity are equally important.

Facial and Body Follicles Become Terminal

In the beard, chest, pubic, axillary, and other androgen-responsive regions, androgen signaling can transform vellus hair into terminal hair. Terminal hairs are thicker, more pigmented, and supported by a larger follicular structure.

Facial beard follicles typically show particularly strong androgen responsiveness. Pubic and axillary follicles can respond at lower androgen thresholds, which is why these regions develop terminal hair differently from the scalp.

Susceptible Scalp Follicles Miniaturize

On genetically susceptible areas such as the frontal hairline and vertex, DHT produces the opposite outcome. Terminal follicles progressively become smaller and produce shorter, finer, less pigmented hairs.

This process is the basis of androgenetic alopecia. DHT-associated signaling shortens the anagen growth phase and can eventually result in substantial follicular miniaturization.

Some Follicles Are Largely Androgen-Independent

Eyelashes and much of the occipital scalp generally show limited androgen dependence compared with beard or frontal-scalp follicles. This regional difference is evidence that androgen effects are governed by local follicle biology rather than hormone exposure alone.

Why Hair-Cycle Biology Matters

Anagen Is the Main Laser Target

Hair follicles cycle through anagen, catagen, and telogen. During anagen, the follicle is actively growing, contains more melanin, and maintains closer structural contact between the hair shaft, matrix, and dermal papilla.

Laser hair removal is therefore most effective when a target follicle is in anagen. A single session cannot treat every follicle equally because follicles within the same body region are distributed across different growth phases.

Multiple Sessions Are Biologically Necessary

After a treatment, follicles that were resting or otherwise less responsive may later enter anagen. Repeated sessions spaced over time allow the clinician to treat additional follicles as they reach a more favorable biological state.

The correct interval depends on the body site, observed regrowth, hair-cycle behavior, and the treatment system. Fixed scheduling without assessing regrowth can reduce efficiency or increase unnecessary exposure.

Androgen Stimulation Can Create New Treatment Targets

In hirsutism or strongly androgen-responsive regions, hormonal signaling may cause previously fine follicles to mature into visible terminal hairs. This can appear as renewed growth even after effective treatment of the terminal hairs that were present initially.

The issue is not necessarily failure of the laser to damage treated follicles. It may reflect newly expressed terminal growth from follicles that were previously too fine or insufficiently pigmented to be effective targets.

How Androgens Influence Laser Hair Removal Protocols

Match Treatment Expectations to Hormonal Biology

Laser hair removal can produce long-term reduction, but it does not remove the underlying androgenic stimulus. Facial hair in hirsute patients and other hormonally responsive areas may therefore require periodic maintenance.

A thorough consultation should distinguish persistent regrowth from the appearance of newly terminalized follicles. Where clinically appropriate, practitioners should also consider whether medical evaluation of an underlying endocrine disorder is warranted.

Selective Photothermolysis Requires a Suitable Chromophore

Laser hair removal uses selective photothermolysis. Melanin, particularly eumelanin in the hair shaft and bulb, absorbs the light and converts it into heat that damages the follicular matrix and related structures.

Coarse terminal hairs are generally better targets because they contain more pigment. Fine vellus hairs contain less melanin and may absorb insufficient energy for reliable follicular injury.

Adjust Wavelength, Fluence, and Pulse Duration

Diode, Alexandrite, and Nd:YAG systems differ in how their wavelengths interact with melanin and tissue. Parameter selection should account for hair thickness, follicle depth, skin pigmentation, body site, and the patient's response to prior sessions.

Deep, coarse, heavily pigmented beard hairs may require carefully selected pulse duration and fluence. Effective epidermal cooling is essential when delivering sufficient energy to the follicle while limiting unwanted heating of the surrounding skin.

Avoid Treating Hair Color as the Only Variable

Hair color is important, but androgen responsiveness also affects hair diameter, depth, density, and the likelihood of future terminalization. A protocol designed for stable coarse body hair may not translate directly to hormonally active facial hair.

The practical goal is to use enough energy to damage the active follicle safely, then reassess response and regrowth before modifying subsequent treatments.

How Androgens Influence Hair-Growth Equipment Protocols

Hair-Growth Therapy Targets a Different Problem

For androgenetic alopecia, the central problem is not unwanted terminal hair. It is progressive miniaturization of scalp follicles under local androgen signaling.

A hair-growth device should therefore be evaluated by whether it supports follicular activity and prolongs or re-establishes productive anagen growth, not simply by whether it produces immediate visible hair.

Low-Level Light Therapy Supports Cellular Activity

Low-level laser or light therapy commonly uses red-light wavelengths in approximately the 600-700 nm range, including systems around 655 nm. The intended mechanism involves photobiomodulation of mitochondrial activity within follicular cells and stem-cell-associated structures.

Increased ATP production and altered cellular metabolism may support follicles transitioning toward anagen and improve the environment for hair production. This does not eliminate the follicle's underlying androgen sensitivity.

Treat Responsive Regions, Not Just Visible Thinning

The frontal and vertex regions are often more androgen-sensitive than the occipital scalp. Treatment planning should account for this regional biology, the degree of miniaturization, hair density, and the proportion of follicles in active or resting phases.

A device protocol should be consistent and longitudinal. Hair-growth changes usually require time because the follicle must progress through biological phases before density and shaft diameter can be assessed reliably.

Combine Device Therapy With Cause-Directed Management

Photobiomodulation may support follicular metabolism, but it is not equivalent to reducing DHT production or blocking androgen-receptor signaling. When androgenetic alopecia is suspected, device-based treatment may need to be considered alongside appropriate topical or systemic medical management.

The appropriate combination depends on diagnosis, contraindications, patient preferences, and clinician oversight. Equipment should not be presented as reversing every hormonal pathway involved in miniaturization.

Understanding the Trade-offs

More Energy Does Not Solve Poor Target Selection

Increasing fluence cannot compensate for a follicle with inadequate pigment, an unsuitable growth phase, or an incorrect wavelength. Excessive energy may instead increase the risk of burns, pigmentary changes, or other thermal injury.

Safe treatment depends on matching energy delivery to the follicle and skin, with cooling and conservative response-based adjustments.

Fine Androgen-Responsive Hair Is Difficult to Treat

Fine hairs may be biologically capable of becoming terminal but remain poor laser targets while they contain little pigment. Treating such hairs aggressively can expose the skin to unnecessary energy without reliably eliminating the follicle.

Clinicians must balance current visibility, pigmentation, hair diameter, and the possibility of future androgen-driven maturation.

Maintenance Is Not Automatically a Sign of Failure

Long-term maintenance may be expected in areas where hormones continue to stimulate follicular activity. The more accurate outcome measure is sustained reduction in visible terminal hair and improved control over time, rather than a promise of permanent absence after a fixed number of sessions.

Photobiomodulation Has Biological Limits

Low-level light therapy may support anagen activity and cellular metabolism, but miniaturized follicles remain hormonally responsive. Treatment consistency and adequate duration matter, and advanced or long-standing miniaturization may limit the achievable response.

Applying This to Equipment Protocols

The most defensible protocol begins with diagnosis and observation rather than equipment settings alone.

If your primary focus is facial or body hair reduction: Plan for multiple anagen-targeted sessions, use parameters based on hair and skin characteristics, and anticipate maintenance when androgenic stimulation remains active.
If your primary focus is hirsutism management: Treat visible terminal hair while recognizing that hormonal evaluation and control may be necessary to limit future terminalization.
If your primary focus is androgenetic alopecia: Use hair-growth equipment to support follicles in miniaturized, androgen-responsive scalp regions, while considering cause-directed medical treatment.
If your primary focus is treatment safety: Prioritize wavelength, fluence, pulse duration, cooling, and skin response over maximum energy delivery.
If your primary focus is outcome assessment: Track hair diameter, density, regrowth timing, and treated-site response across several cycles rather than judging results from a single session.

Understanding the follicle's local androgen biology allows equipment protocols to be precise, realistic, and aligned with the mechanism driving the patient's hair growth or hair loss.

Summary Table:

Aspect	Androgenic Effect on Hair Follicles	Clinical Implication
Androgen-dependent sites (face, body)	Vellus → terminal hair	Laser targets thick, pigmented hairs; maintenance may be needed due to ongoing hormonal stimulation
Androgen-sensitive scalp (frontal, vertex)	Terminal → miniaturization	Hair growth devices support follicle metabolism; combine with medical management
Androgen-independent sites (eyelashes, occiput)	Minimal effect	Standard protocols apply
Hair cycle	Anagen is active growth; laser most effective in anagen	Multiple sessions spaced to align with cycles
Hormonal influence	DHT stimulates follicle changes	For hirsutism, address hormonal evaluation; for alopecia, consider DHT blockers

Enhance your practice with BELIS's advanced aesthetic equipment, designed to address androgen-driven hair concerns. Our portfolio includes laser systems (Diode, Alexandrite, Nd:YAG, Pico), IPL, and PDT devices, plus low-level laser therapy for hair growth. Whether you're treating hirsutism or androgenetic alopecia, our solutions help you achieve optimal outcomes. Contact us today to learn how BELIS can support your clinical success.